Embracing Future Holdings Limited (SGX:8YY)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0240
0.00 (0.00%)
At close: Oct 10, 2025
Market Cap41.60M
Revenue (ttm)2.49M
Net Income (ttm)-2.61M
Shares Out1.73B
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume356,200
Average Volume2,486,580
Open0.0250
Previous Close0.0240
Day's Range0.0230 - 0.0250
52-Week Range0.0080 - 0.0330
Beta0.47
RSI56.86
Earnings DateOct 31, 2025

About Embracing Future Holdings

Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 b... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2009
Employees 7
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 8YY
Full Company Profile

Financial Performance

In 2024, Embracing Future Holdings's revenue was 858,000, an increase of 176.77% compared to the previous year's 310,000. Losses were -3.43 million, 38.0% more than in 2023.

Financial Statements

News

There is no news available yet.